• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Implementing quality assurance programs in multigroup practices for treating hypercholesterolemia in patients with coronary artery disease.

作者信息

Gerber J

机构信息

Yale University School of Medicine, New Haven, Connecticut, USA.

出版信息

Am J Cardiol. 1997 Oct 30;80(8B):57H-61H. doi: 10.1016/s0002-9149(97)00822-9.

DOI:10.1016/s0002-9149(97)00822-9
PMID:9373000
Abstract

Healthcare reform is driving the development of specialty physician practices into larger regional and national physician networks. These networks arise from the federation of > or =2 practices that negotiate with managed-care organizations for contracts. Developing cardiovascular networks and establishing and implementing lipid management quality assurance programs into the network are presented in this article. Goals of the lipid management program include enhancing the identification, diagnosis, education, and comprehensive treatment of patients with cardiovascular disease. Utilizing an integrated, coordinated, multidisciplinary approach to lipid management allows the cardiology network to improve patients' quality of life, reduce long-term costs, and gain a competitive advantage for successful contracting. A network lipid management program involves targeting eligible patients and treating them to a targeted level for low-density lipoprotein (LDL) cholesterol where possible. Among cardiologists, there is a consensus that achieving an LDL cholesterol of < 100 mg/dL for patients with pre-existing cardiovascular disease is desirable. Secondary lipid management program goals include: (1) collecting, storing, and analyzing patient demographics; (2) implementing programs involving lifestyle modification, smoking cessation, weight control; and (3) measuring clinical and economic outcomes. Convergence of several driving forces in managing hypercholesterolemia provides cardiologists with the ability to improve the process. These forces include: market-consolidated delivery systems, established lipid management guidelines, and employer-initiated policies requiring higher quality care within managed-care organizations. Methods to achieve enhanced treatment effectiveness, patient satisfaction, and control costs are discussed. Utilizing multidisciplinary teams including nurse case managers, clinical pharmacists, dietitians, and physician assistants to achieve lipid level goals and for nutritional counseling is desirable. Developing disease state management programs, treatment algorithms, databases with analytic reports, and process improvement across the network is of paramount importance for future progress and success.

摘要

相似文献

1
Implementing quality assurance programs in multigroup practices for treating hypercholesterolemia in patients with coronary artery disease.
Am J Cardiol. 1997 Oct 30;80(8B):57H-61H. doi: 10.1016/s0002-9149(97)00822-9.
2
Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists.
Am J Cardiol. 1997 Oct 30;80(8B):39H-44H. doi: 10.1016/s0002-9149(97)00819-9.
3
Lipid management in a private cardiology practice (the Midwest Heart experience).
Am J Cardiol. 2000 Feb 10;85(3A):18A-22A. doi: 10.1016/s0002-9149(99)00934-0.
4
Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.在一项心脏保健倡议之后,心脏病学集体医疗实践和医院环境中的二级预防。
Am J Cardiol. 2000 Feb 10;85(3A):23A-29A. doi: 10.1016/s0002-9149(99)00935-2.
5
Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy.实现心脏病患者低密度脂蛋白胆固醇的国家胆固醇教育计划目标:饮食、运动、体重控制和药物治疗的重要性。
Mayo Clin Proc. 1999 May;74(5):466-73. doi: 10.4065/74.5.466.
6
Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease.
JAMA. 2000 Jan 5;283(1):94-8. doi: 10.1001/jama.283.1.94.
7
Reaching National Cholesterol Education Program Goals: a managed care approach to improving hyperlipidemia disease management outcomes. Introduction.
Am J Med. 2001 Apr 16;110 Suppl 6A:1S-2S. doi: 10.1016/s0002-9343(01)00671-4.
8
9
Clinical performance improvement series. Classic CQI integrated with comprehensive disease management as a model for performance improvement.临床绩效改进系列。将经典的持续质量改进与综合疾病管理相结合作为绩效改进的模式。
Jt Comm J Qual Improv. 1999 Aug;25(8):383-95. doi: 10.1016/s1070-3241(16)30453-9.
10
Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction.冠状动脉疾病二级预防及左心室功能障碍治疗中指南推荐药物治疗的性能评估模型
Am J Cardiol. 1997 Oct 30;80(8B):53H-56H. doi: 10.1016/s0002-9149(97)00821-7.

引用本文的文献

1
Patient and physician satisfaction with a telephone-based anticoagulation service.患者和医生对基于电话的抗凝服务的满意度。
J Gen Intern Med. 2001 Jul;16(7):460-3. doi: 10.1046/j.1525-1497.2001.016007460.x.